ARCT vs RIDE
Arcturus Therapeutics Holdings Inc (ARCT) versus RIDE (RIDE) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
RIDE (RIDE) common stock.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
RIDE does not have a complete income-statement cache yet.
ARCT currently screens at market cap $369.4M.
Not investment advice. Open the ARCT and RIDE stock pages for the full models.
Not investment advice.